Pharmaceuticals

Global Oxycodone Drugs Market Overview: Trends Shaping Growth to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Oxycodone Drugs Industry Expected To Reach By 2029, Starting From 2025 Levels?

The oxycodone drugs market size has experienced significant growth in recent years. It is anticipated to expand from $5.62 billion in 2024 to $5.98 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.4%. The expansion observed in prior periods can be attributed to factors such as an intensive marketing effort for OxyContin, which was promoted for chronic non-malignant pain and cancer. The subsequent rise in OxyContin prescriptions for non-cancer-related pain also fueled the demand for these drugs. Furthermore, synthetic opiates, including oxycodone, started to enter the market in larger quantities following the Second World War.

The oxycodone drugs market is projected to experience substantial expansion over the upcoming years. By 2029, its valuation is anticipated to reach $7.66 billion, demonstrating a compound annual growth rate (CAGR) of 6.4%. This anticipated growth is driven by several factors including the rising occurrence of chronic pain, an increase in surgical interventions, continuous advancements within the product pipeline, improvements in drug delivery systems, and a globally expanding elderly population facing a greater frequency of chronic pain conditions. Key trends anticipated during this forecast duration encompass a heightened demand for abuse-deterrent formulations (ADFS), the innovation of new delivery methods, the expanding adoption of combination therapies, and progress in manufacturing technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Which Factors And Drivers Are Influencing The Oxycodone Drugs Market In 2025?

The significant prevalence of orthopedic conditions is predicted to fuel the expansion of the oxycodone drug market moving ahead. Orthopedic disorders encompass various musculoskeletal ailments affecting bones, joints, ligaments, tendons, and muscles, resulting in discomfort, restricted movement, and functional limitations. The increasing occurrence of orthopedic conditions stems from an aging demographic, inactive routines, excess weight, athletic injuries, and workplace risks. For orthopedic disorders, oxycodone medications are employed to mitigate both acute and persistent pain arising from issues like fractures, joint damage, or post-operative discomfort, offering potent relief through their action on pain receptors within the central nervous system. As an example, in October 2023, data from the Institute for Health Metrics and Evaluation, a US-based research body, indicated that the projected number of musculoskeletal disorders (orthopedic disorders) is expected to increase by 115% (ranging from 107–124%) between 2020 and 2050, reaching an estimated 1,060 million existing cases by 2050. Consequently, the substantial impact of orthopedic disorders is propelling the expansion of the oxycodone drug market.

What Are The Leading Segments Analyzed In The Oxycodone Drugs Market?

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

What Long-Term Trends Will Shape The Future Growth Of The Oxycodone Drugs Industry?

Key companies operating in the oxycodone drug sector are focusing on developing innovative medications, such as oxycodone immediate-release (IR) tablets, to lessen drug abuse through injection and intranasal administration. Oxycodone immediate-release (IR) tablets are a specific form of the opioid analgesic oxycodone, formulated to offer quick pain relief. For instance, in July 2022, Protega Pharmaceuticals LLC, a US-based pharmaceutical enterprise, launched RoxyBond (oxycodone) immediate-release (IR) tablets in the United States. RoxyBond has received authorization from the U.S. Food and Drug Administration (FDA) as an opioid agonist intended for managing severe pain when other treatment options are insufficient. It integrates advanced technology to prevent misuse and abuse, making it challenging to physically or chemically tamper with.

Which Major Firms Are Strengthening Their Position In The Oxycodone Drugs Industry?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Oxycodone Drugs Market?

North America was the largest region in the oxycodone drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Oxycodone Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp

Browse Through More Reports Similar to the Global Oxycodone Drugs Market 2025, By The Business Research Company

Narcotic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/focal-segmental-glomerulosclerosis-drugs-global-market-report

Antiparasitic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795